Multiple Sclerosis News

USC PhD Student Creates Project to Treat MS with Nanotechnology

A Ph.D. student at theĀ University of Southern California (USC) Viterbi Ming Hsieh Department of Electrical Engineering, Kun Yue, is developing a model of selected brain circuits to study multiple sclerosis (MS) in an effort to develop a nanotechnology based treatment for the disease.Ā Yue believes that new technology can lead…

Antihistamine Repurposed for Remyelination in Phase 2 Trial from UCSF

The University of California, San Francisco (UCSF) initiated a clinical trial to evaluate the antihistamine clemastine fumarate, manufactured by Novartis as Tavist, for its efficacy in treating multiple sclerosis patients. The laboratory of Dr. Jonah Chan, a professor of neurology at UCSF, used a high-throughput method to identify Tavist…

Cleveland Clinic Researchers Find iPad A Powerful Multiple Sclerosis Assessment Tool

Tracking patients’ progress is a critical part of MS management, a process that can benefit from greater objective analysis. Researchers at the Cleveland Clinic have determined that tablet computers, which feature built-in technologies like accelerometers, gyroscopes, and touchscreens, when combined with appropriate software, can provide pretty good MS assessment capabilities.

Actavis Plans Generic Version of Acorda’s Multiple Sclerosis Drug Ampyra

Acorda TherapeuticsĀ recently announced receiving a notice letter from pharmaceutical companyĀ Actavis PlcĀ indicating theirĀ plansĀ to commercialize a generic version of Ampyra, Acorda’s multiple sclerosis treatment drug. Acorda claims that Actavis submitted a marketing approval application with the U.S. Food and Drug Administration (FDA) asking permission to develop and commercialize a new drug,…

Hilton Foundation Opens Submissions for Innovation Award in MS

The Conrad N. Hilton Foundation is accepting submissions for the first edition of the MarilynĀ HiltonĀ Award for Innovation in Multiple Sclerosis Research, which will support novelĀ and potentially paradigm-shifting research on Progressive Multiple Sclerosis (MS). The award will grant up to $6 million in funding to several projects over a four-year…

Roche Turns to MS Research on Agreement with Versant Ventures

The Swiss pharmaceutical companyĀ RocheĀ recently announced a partnership agreement with California-based Inception Sciences and venture capital firm Versant Ventures. The three companies will work together to form a new company, Inception 5, which will be dedicated mostly to the development of therapies for multiple sclerosis. Inception 5’s research will focus…

Physiotherapist Creates Group Exercise Manual for MS Patients

Group exercise could be very beneficial in improving the health of multiple sclerosis patients, according to Sheila Lennon, Physiotherapy ProfessorĀ fromĀ Flinders University, in Adelaide, Australia. Lennon is the creator of a new training manual for clinicians, as she advocates the need forĀ regular and ongoing physiotherapy in the public health system.

Natalizumab, Other Biogen Idec MS Therapies Featured at Medical Congresses; Company Joins Sailing Sclerosis Foundation Oceans of Hope Project

Biogen Idec, a U.S. biotechnology company specializing in therapies for neurological disorders, autoimmune disorders and cancer, has announced that more than 60 company-sponsored presentations highlighting key data from its extensive portfolio of marketed and investigational multiple sclerosis (MS) therapies were featured during two 2014 neurology conferences. The company…

Researcher Recommends Brain Imaging To Treat MS-Related Depression

Magnetic resonance imaging (MRI) can predict responses to depression treatment in patients with multiple sclerosis (MS), according to Anthony Feinstein, Professor at the Department of Psychiatry of the Sunnybrook Health Sciences Centre & the University of Toronto. In the presentation ā€œDepression in MS: Is brain imaging helpful?ā€ at this…